CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2024

Conditions
Mitral Valve Regurgitation
Interventions
DEVICE

Transcatheter Mitral Valve Re-placement (TMVR) with the CardiAQ-Edwards™ Transcatheter Mitral Valve

Replacement of the mitral valve through a transcatheter approach

Trial Locations (15)

2100

Rigshospitalet, Copenhagen

3010

InselSpital Bern, Bern

13353

Deutsche Herzzentrum Berlin, Berlin

20132

Ospedale San Raffaele, Milan

20146

University Heart Centre, Hamburg

50937

Herzzentrum der UniKlinik Köln, Cologne

59000

Centre Hospitalier Régional Universitaire de Lille, Lille

61231

Kerckhoff-Klinik GmbH, Bad Nauheim

V6Z 1Y6

St. Paul's Hospital, University of British Columbia, Vancouver

M5B 1W8

St. Michael's Hospital, Toronto

M5G 2C4

Centre Toronto General Hospital, Toronto

G1V 4G5

Centre de recherche Institut Universitaire de Cardiologie et de Pneumologie de Québec (CRIUCPQ), Québec

04289

Leipzig Herzzentrum, Leipzig

00133

Universita di Roma Tor Vergata, Roma

3015 CE

Erasmus Medical Centre, Rotterdam

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY